Literature DB >> 21745430

Intranasal delivery of drugs to eustachian tube orifice.

Y G Karagama1, M Rashid, J L Lancaster, A Karkanevatos, R S William.   

Abstract

BACKGROUND: Intranasal medication administration which aims to deliver to the eustachian tube orifice has been adopted for the management of a number of otological conditions, acting via a reduction in tubal oedema and improved ventilation. Evidence for the optimal head position for such drug administration is limited. We compared four different positions and also assessed spray versus drop formulation, to determine optimal delivery conditions.
METHODS: Prospective, five-period, cross-over study using methylene blue dyed saline in a drops or spray container. Five healthy volunteers tested the Mygind, Ragan, Mecca and 'head back' head positions. Nasal spray drug delivery in the most effective head position was then compared with drops drug delivery (administered in the head back position). Intranasal delivery was assessed photographically using a 30° rigid naso-endoscope.
RESULTS: Maximal nasal drops delivery was achieved with the Mygind and Ragan positions. Drops were more successful than spray in reaching the eustachian tube orifice.
CONCLUSION: The Mygind and Ragan positions are best for eustachian tube orifice drug delivery, and drops preparations are better than spray preparations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745430     DOI: 10.1017/S0022215111001125

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

Review 1.  Rationale and feasibility of intranasal delivery of drugs to the eustachian tube orifice.

Authors:  Mamun Rashid
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.